UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): March 18, 2013
M.D.C. Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware | 1-8951 | 84-0622967 | ||
(State or other jurisdiction of incorporation) |
(Commission file number) |
(I.R.S. employer identification no.) |
4350 South Monaco Street, Suite 500, Denver, Colorado 80237
(Address of principal executive offices) (Zip code)
Registrants telephone number, including area code: (303) 773-1100
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 5.07 | SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS |
On March 18, 2013, M.D.C. Holdings, Inc. (the Company) held its 2013 annual meeting of shareholders. There were 48,698,757 shares of common stock entitled to vote at the meeting. The final results for each of the matters submitted to a vote of shareholders at the annual meeting were as follows:
(1) | The following individuals were elected as Class I Directors of the Company to serve for three-year terms expiring in 2016: |
For | Withheld | Broker Non-Votes | ||||||||
Michael A. Berman |
41,847,516 | 770,207 | 3,466,665 | |||||||
Herbert T. Buchwald |
41,792,256 | 825,467 | 3,466,665 | |||||||
Larry A. Mizel |
41,502,472 | 1,115,251 | 3,466,665 |
(2) | The M.D.C. Holdings, Inc. 2013 Executive Officer Performance-Based Compensation Plan was approved: |
For |
Against |
Abstain |
Broker Non-Votes | |||
42,127,070 | 479,611 | 11,042 | 3,466,665 |
(3) | The amendment to the M.D.C. Holdings, Inc. 2011 Equity Incentive Plan was approved: |
For |
Against |
Abstain |
Broker Non-Votes | |||
37,987,240 | 4,443,171 | 187,312 | 3,466,665 |
(4) | In a non-binding advisory vote, the compensation of the Companys named executive officers was approved: |
For |
Against |
Abstain |
Broker Non-Votes | |||
40,860,203 | 1,145,498 | 612,022 | 3,466,665 |
(4) | The selection of Ernst & Young LLP as the Companys independent registered public accounting firm for the 2013 fiscal year was approved: |
For |
Against |
Abstain |
Broker Non-Votes | |||
45,550,256 | 529,764 | 4,368 | |
ITEM 9.01. | FINANCIAL STATEMENTS AND EXHIBITS |
9.01(d) Exhibits
Exhibit No. |
Description | |
10.1 | The M.D.C. Holdings, Inc. 2013 Executive Officer Performance-Based Compensation Plan | |
10.2 | First Amendment to the M.D.C. Holdings, Inc. 2011 Equity Incentive Plan |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
M.D.C. HOLDINGS, INC. | ||||||
Dated: March 19, 2013 | By: | /s/ Joseph H. Fretz | ||||
Joseph H. Fretz | ||||||
Secretary and Corporate Counsel |
3
Exhibit Index
Exhibit No. |
Description | |
10.1 | The M.D.C. Holdings, Inc. 2013 Executive Officer Performance-Based Compensation Plan | |
10.2 | First Amendment to the M.D.C. Holdings, Inc. 2011 Equity Incentive Plan |
4